Scott Dunseth Myers - Chief Executive Officer, Director at Viridian Therapeutics, Inc.\DE

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
VRDN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Scott Dunseth Myers since 07 Mar 2025

Holdings reported by Scott Dunseth Myers for Viridian Therapeutics, Inc.\DE

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 259,500 $5,449,500 $21.00 12 Apr 2023 Direct

Transactions reported by Scott Dunseth Myers for Viridian Therapeutics, Inc.\DE

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.